Jaume Puig‐Junoy

3.9k total citations
140 papers, 2.8k citations indexed

About

Jaume Puig‐Junoy is a scholar working on Economics and Econometrics, General Health Professions and Management Science and Operations Research. According to data from OpenAlex, Jaume Puig‐Junoy has authored 140 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Economics and Econometrics, 43 papers in General Health Professions and 14 papers in Management Science and Operations Research. Recurrent topics in Jaume Puig‐Junoy's work include Health Systems, Economic Evaluations, Quality of Life (70 papers), Pharmaceutical Economics and Policy (44 papers) and Healthcare Policy and Management (39 papers). Jaume Puig‐Junoy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (70 papers), Pharmaceutical Economics and Policy (44 papers) and Healthcare Policy and Management (39 papers). Jaume Puig‐Junoy collaborates with scholars based in Spain, Netherlands and Brazil. Jaume Puig‐Junoy's co-authors include Guillém López i Casasnovas, Juan Oliva, Anna García‐Altés, Fernando Antoñanzas, Ramón Gisbert, Javier Mar, Vicente Ortún Rubio, José Luis Pinto Prades, Julio López Bastida and Julio López‐Bastida and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and International Journal of Environmental Research and Public Health.

In The Last Decade

Jaume Puig‐Junoy

131 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Puig‐Junoy Spain 26 1.4k 580 267 265 248 140 2.8k
Zoltán Kaló Hungary 31 1.8k 1.3× 577 1.0× 115 0.4× 173 0.7× 242 1.0× 225 3.6k
Nikos Maniadakis Greece 23 709 0.5× 296 0.5× 242 0.9× 198 0.7× 77 0.3× 125 1.9k
José Luis Pinto Prades Spain 27 2.2k 1.5× 981 1.7× 202 0.8× 119 0.4× 157 0.6× 95 3.2k
Michael A. Morrisey United States 42 2.3k 1.6× 1.9k 3.3× 140 0.5× 260 1.0× 306 1.2× 189 5.1k
Dimitris Niakas Greece 36 1.1k 0.8× 1.8k 3.1× 365 1.4× 120 0.5× 419 1.7× 170 4.7k
Darius Lakdawalla United States 41 2.4k 1.7× 2.0k 3.5× 77 0.3× 168 0.6× 245 1.0× 206 5.9k
Panos Kanavos United Kingdom 43 3.5k 2.5× 973 1.7× 86 0.3× 271 1.0× 266 1.1× 226 6.0k
Nick Kontodimopoulos Greece 29 931 0.7× 790 1.4× 295 1.1× 107 0.4× 270 1.1× 80 2.7k
Axel Mühlbacher Germany 27 1.8k 1.3× 1.0k 1.7× 69 0.3× 119 0.4× 336 1.4× 108 3.4k
David K. Whynes United Kingdom 31 1.2k 0.9× 800 1.4× 66 0.2× 413 1.6× 511 2.1× 151 3.4k

Countries citing papers authored by Jaume Puig‐Junoy

Since Specialization
Citations

This map shows the geographic impact of Jaume Puig‐Junoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Puig‐Junoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Puig‐Junoy more than expected).

Fields of papers citing papers by Jaume Puig‐Junoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Puig‐Junoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Puig‐Junoy. The network helps show where Jaume Puig‐Junoy may publish in the future.

Co-authorship network of co-authors of Jaume Puig‐Junoy

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Puig‐Junoy. A scholar is included among the top collaborators of Jaume Puig‐Junoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Puig‐Junoy. Jaume Puig‐Junoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trapero‐Bertran, Marta, et al.. (2025). Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing. Gaceta Sanitaria. 39. 102439–102439. 2 indexed citations
2.
Trapero‐Bertran, Marta, Juan Oliva, Ferrán Catalá-López, et al.. (2025). Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing. Gaceta Sanitaria. 39. 102448–102448. 1 indexed citations
3.
4.
Campillo-Artero, Carlos, et al.. (2019). Price Models for Multi-indication Drugs: A Systematic Review. Applied Health Economics and Health Policy. 18(1). 47–56. 31 indexed citations
5.
Puig‐Junoy, Jaume, et al.. (2018). Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review. Expert Review of Gastroenterology & Hepatology. 12(12). 1251–1263. 11 indexed citations
6.
Puig‐Junoy, Jaume, et al.. (2017). [Socioeconomic Costs of Asthma in the European Union, United States and Canada: A Systematic Review].. PubMed. 91. 7 indexed citations
7.
Puig‐Junoy, Jaume, et al.. (2017). COSTES SOCIOECONÓMICOS DEL ASMA EN LA UNIÓN EUROPEA, ESTADOS UNIDOS Y CANADÁ: REVISIÓN SISTEMÁTICA. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Puig‐Junoy, Jaume, et al.. (2017). Non-healthcare costs of hepatitis C: a systematic review. Expert Review of Gastroenterology & Hepatology. 12(1). 19–30. 10 indexed citations
9.
Puig‐Junoy, Jaume, et al.. (2016). [Impact of the Pharmaceutical Copayment Reform on the Use of Antidiabetics, Antithrombotics and for Chronic Obstructive Airway Disease Agents, Spain].. PubMed. 90. E6–E6. 8 indexed citations
10.
Oliva, Juan & Jaume Puig‐Junoy. (2014). Guías y recomendaciones para la realización de evaluaciones económicas y análisis de impacto presupuestario de medicamentos presentadas al Servei Català de la Salut: ¿un verso suelto o una palanca de cambio?. 18–19. 4 indexed citations
11.
López-Valcarcel, Beatríz González, et al.. (2012). La crisis económica llega a la sanidad pública. Economistas. 30(131). 158–162. 2 indexed citations
12.
Puig‐Junoy, Jaume, et al.. (2009). [Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease].. PubMed. 24(4). 220–9. 9 indexed citations
13.
Puig‐Junoy, Jaume. (2007). La financiación y la regulación del precio de los medicamentos en el Sistema Nacional de Salud: cambios y continuidad. Hispana. 8 indexed citations
14.
Puig‐Junoy, Jaume. (2004). Los medicamentos genéricos pagan el precio de ser referencia. 2(1). 35–59. 9 indexed citations
15.
Hernández, C, Alejandro Casas, Joan Escarrabill, et al.. (2003). Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. European Respiratory Journal. 21(1). 58–67. 173 indexed citations
16.
Puig‐Junoy, Jaume. (2001). Los mecanismos de copago en servicios sanitarios: cuándo, cómo y por qué. Revista Hacienda Pública Española. 158(158). 105–134. 5 indexed citations
17.
Puig‐Junoy, Jaume. (1999). Managing risk selection incentives in health sector reforms. The International Journal of Health Planning and Management. 14(4). 287–311. 1 indexed citations
18.
Casasnovas, Guillém López i & Jaume Puig‐Junoy. (1999). La aplicación de precios de referencia a los medicamentos. Cuadernos de Información económica. 77–84. 3 indexed citations
19.
Puig‐Junoy, Jaume. (1997). La descentralización del gasto sanitario. 68–74.
20.
Puig‐Junoy, Jaume. (1988). Gasto farmacéutico en España: efectos de la participación del usuario en el coste. Investigación Económica. 12(1). 45–68. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zoltán Kaló Breakdown of academic impact, for papers by Nikos Maniadakis Breakdown of academic impact, for papers by José Luis Pinto Prades Breakdown of academic impact, for papers by Michael A. Morrisey Breakdown of academic impact, for papers by Dimitris Niakas Breakdown of academic impact, for papers by Darius Lakdawalla Breakdown of academic impact, for papers by Panos Kanavos Breakdown of academic impact, for papers by Nick Kontodimopoulos Breakdown of academic impact, for papers by Axel Mühlbacher Breakdown of academic impact, for papers by David K. Whynes
Rankless by CCL
2026